Goodman Noah sold KYMR
April 9, 2026 · Form 4 insider transaction
Goodman Noah sold 2,500 shares of Kymera Therapeutics, Inc. at $89.00 per share, a transaction worth $222.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,500
Price
$89.00
Total value
$222.5K
InsiderGoodman Noah
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 9, 2026
Filing dateApril 10, 2026
Shares owned after53,542
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.